DCGI

DCGI gives limited approval to market Stempeutics’ allogeneic cell therapy

Stempeucel is used in the treatment of Buerger’s disease

DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?

Abhijeet Das, Senior Associate, Singhania and Partners, opines that there are multiple fronts on which the aggrieved pharma companies can contest the ban On March 10, 2016, vide its notifications bearing S.O. 705(E) through S

Indian scientists develop breakthrough dengue drug

The project was jointly undertaken by DBT, ICGEB and Ranbaxy Research Laboratory and employed Ayurveda in devising the drug In a breakthrough move that can help in the fight against dengue, a herbal medicine against it is cla

Hetero receives DCG(I) approval for fixed-dose combination therapy ‘Ledipasvir-Sofosbuvir’

The product will be available under the brand name ‘Ledisof’ in India

New drug capsule shells offer new choice: veg or non-veg

Expert panel to meet tomorrow to decide on gelatin versus cellulose Veg or non-veg? Not too far in the future, the person asking you that question might just be your neighbourhood chemist. For, a scientific committee advising

Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Most Read

Advertisement

Budget 2020

Advertisement

Related Articles